Expression of DKK1 in Endometrial Endometrioid Carcinoma and Its Correlation with Wnt/β-catenin Signalling Pathway.

Endometrioid Carcinoma DKK1 Wnt/β-catenin pathway β-catenin E-cadherin India pmc-status-qastatus 0 pmc-status-live yes pmc-status-embargo no pmc-status-released yes pmc-prop-open-access yes pmc-prop-olf no pmc-prop-manuscript no pmc-prop-legally-suppressed no pmc-prop-has-pdf yes pmc-prop-has-supplement no pmc-prop-pdf-only no pmc-prop-suppress-copyright no pmc-prop-is-real-version no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes pmc-license-ref CC BY-ND Advances in Knowledge - DKK1 shows a decreasing trend of immunoexpression from the benign phase of the endometrium to endometrioid endometrial carcinoma . - Expression of DKK1 is well correlated with the markers of the Wnt signalling pathway (β-catenin, E-cadherin and c-Myc) . - DKK1 antagonises the Wnt signalling pathway .

also in 47,180 other papers